Motif BioSciences, Inc.

Amphion Innovations, plc.

Amphion Innovations plc (LSE: AMP) builds shareholder value in high growth companies in the medical and technology sectors, by using a focused, hands-on company building approach, based on decades of experience in both the US and UK.

Amphion has significant shareholding in 8 Partner Companies developing proven technologies targeting substantial commercial marketplaces, each in excess of $1 billion. Each Partner Company is chosen with the goal of achieving an exit valuation in excess of $100 million.

Amphion also has two specialized entities, MSA Holding, a joint venture intended to replicate the Amphion model in the Gulf, and DataTern, Inc., established to exploit IP opportunities within the Company's Partner Companies.

www.amphionplc.com

Home
Company
Management
Scientific Board
Partners
News
Contact
World Wide Web Solutions